These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mucosal immunity and protection against HIV/SIV infection: strategies and challenges for vaccine design. Demberg T; Robert-Guroff M Int Rev Immunol; 2009; 28(1):20-48. PubMed ID: 19241252 [TBL] [Abstract][Full Text] [Related]
5. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. Velu V; Kannanganat S; Ibegbu C; Chennareddi L; Villinger F; Freeman GJ; Ahmed R; Amara RR J Virol; 2007 Jun; 81(11):5819-28. PubMed ID: 17376899 [TBL] [Abstract][Full Text] [Related]
6. High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum. LaFranco-Scheuch L; Abel K; Makori N; Rothaeusler K; Miller CJ J Virol; 2004 Jun; 78(12):6399-408. PubMed ID: 15163733 [TBL] [Abstract][Full Text] [Related]
7. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques. Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726 [TBL] [Abstract][Full Text] [Related]
8. A replication competent adenovirus 5 host range mutant-simian immunodeficiency virus (SIV) recombinant priming/subunit protein boosting vaccine regimen induces broad, persistent SIV-specific cellular immunity to dominant and subdominant epitopes in Mamu-A*01 rhesus macaques. Malkevitch N; Patterson LJ; Aldrich K; Richardson E; Alvord WG; Robert-Guroff M J Immunol; 2003 Apr; 170(8):4281-9. PubMed ID: 12682263 [TBL] [Abstract][Full Text] [Related]
9. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251. Lü X; Kiyono H; Lu D; Kawabata S; Torten J; Srinivasan S; Dailey PJ; McGhee JR; Lehner T; Miller CJ AIDS; 1998 Jan; 12(1):1-10. PubMed ID: 9456249 [TBL] [Abstract][Full Text] [Related]
10. Progress towards a vaccine to prevent sexual transmission of HIV. Miller CJ; McGhee JR Nat Med; 1996 Jul; 2(7):751-2. PubMed ID: 8673919 [No Abstract] [Full Text] [Related]
11. Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm. Nilsson C; Mäkitalo B; Thorstensson R; Norley S; Binninger-Schinzel D; Cranage M; Rud E; Biberfeld G; Putkonen P AIDS; 1998 Dec; 12(17):2261-70. PubMed ID: 9863867 [TBL] [Abstract][Full Text] [Related]
12. Durable protection of rhesus macaques immunized with a replicating adenovirus-SIV multigene prime/protein boost vaccine regimen against a second SIVmac251 rectal challenge: role of SIV-specific CD8+ T cell responses. Malkevitch NV; Patterson LJ; Aldrich MK; Wu Y; Venzon D; Florese RH; Kalyanaraman VS; Pal R; Lee EM; Zhao J; Cristillo A; Robert-Guroff M Virology; 2006 Sep; 353(1):83-98. PubMed ID: 16814356 [TBL] [Abstract][Full Text] [Related]
13. Assessment of the relative therapeutic effects of vaccines on virus load and immune responses in small groups at several time points: efficacy of mucosal and subcutaneous polypeptide vaccines in rhesus macaques exposed to SHIV. Kuznetsov VA; Stepanov VS; Berzofsky JA; Belyakov IM J Clin Virol; 2004 Dec; 31 Suppl 1():S69-82. PubMed ID: 15567097 [TBL] [Abstract][Full Text] [Related]
14. Mucosal Vaccination for Prevention of HIV Infection and AIDS. Aldovini A Curr HIV Res; 2016; 14(3):247-59. PubMed ID: 26957199 [TBL] [Abstract][Full Text] [Related]
15. Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. Cromwell MA; Veazey RS; Altman JD; Mansfield KG; Glickman R; Allen TM; Watkins DI; Lackner AA; Johnson RP J Virol; 2000 Sep; 74(18):8762-6. PubMed ID: 10954580 [TBL] [Abstract][Full Text] [Related]
16. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV. Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554 [TBL] [Abstract][Full Text] [Related]
17. Contrasting effects of low-dose IL-2 on vaccine-boosted simian immunodeficiency virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251. Nacsa J; Edghill-Smith Y; Tsai WP; Venzon D; Tryniszewska E; Hryniewicz A; Moniuszko M; Kinter A; Smith KA; Franchini G J Immunol; 2005 Feb; 174(4):1913-21. PubMed ID: 15699118 [TBL] [Abstract][Full Text] [Related]
18. A rational basis for mucosal vaccination against HIV infection. Lehner T; Bergmeier L; Wang Y; Tao L; Mitchell E Immunol Rev; 1999 Aug; 170():183-96. PubMed ID: 10566151 [TBL] [Abstract][Full Text] [Related]
19. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002 [TBL] [Abstract][Full Text] [Related]
20. Global dysfunction of CD4 T-lymphocyte cytokine expression in simian-human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination. McKay PF; Barouch DH; Schmitz JE; Veazey RS; Gorgone DA; Lifton MA; Williams KC; Letvin NL J Virol; 2003 Apr; 77(8):4695-702. PubMed ID: 12663776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]